Your Article Summary
Regulatory update: mepolizumab for the treatment of hypereosinophilic syndrome
GlaxoSmithKline, 08/05/09
GSK announced that it has notified the European Medicines Agency of its decision to withdraw the Marketing Authorisation Application in the EU for mepolizumab for the treatment of hypereosinophilic syndrome.
Related Articles
Successful Treatment With Sumatriptan in a Case With Cyclic Vomiting Syndrome Combined With 18q– Syndrome
Journal of Child Neurology, 10/02/09
Relevance Score: 47%
Metabolic Syndrome Among College Students
The Journal for Nurse Practitioners, 11/19/09
Relevance Score: 46%
Common infectious agents prevalence in antiphospholipid syndrome
Lupus, 11/05/09
Relevance Score: 46%
A Prospective Investigation of Biomechanical Risk Factors for Patellofemoral Pain Syndrome: The Joint Undertaking to Monitor and Prevent ACL Injury (JUMP-ACL) Cohort
American Journal of Sports Medicine, 11/02/09
Relevance Score: 46%
Adult-onset Still’s disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood
Zeitschrift für Rheumatologie, 10/29/09
Relevance Score: 46%
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Medicine, 12/02/09
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Article Search
Sponsor


See Latest Articles


